Yousif Capital Management’s Krystal Biotech KRYS Stock Holding History

Yousif Capital Management’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.67M	Buy	7,192 +61	+0.9%	+$18.2K	0.03%	550
2026 Q1	$1.84M	Sell	7,131 -36	-0.5%	-$9.58K	0.02%	702
2025 Q4	$1.97M	Sell	7,167 -1,050	-13%	-$221K	0.02%	713
2025 Q3	$1.45M	Sell	8,217 -1,383	-14%	-$207K	0.02%	897
2025 Q2	$1.32M	Buy	9,600 +30	+0.3%	+$4.41K	0.01%	973
2025 Q1	$1.73M	Sell	9,570 -207	-2%	-$34.8K	0.02%	797
2024 Q4	$1.53M	Sell	9,777 -172	-2%	-$30.5K	0.02%	906
2024 Q3	$1.81M	Sell	9,949 -155	-2%	-$29.9K	0.02%	833
2024 Q2	$1.86M	Buy	+10,104	New	+$1.7M	0.02%	796

Other funds holding KRYS

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

TAM

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

CWS

Confluence Wealth Services Mcmurray, Pennsylvania $3.5B AUM 22.08% 1-Year Est. Return

Yousif Capital Management's KRYS Position: Q2 2026 in Review

Yousif Capital Management increased its Krystal Biotech (KRYS) stake by 0.86% in Q2 2026, buying an estimated $18.2K and bringing the position to 7,192 shares worth $2.67M. The position accounts for 0.03% of the portfolio, ranked #550.

Yousif Capital Management first reported a position in KRYS in Q2 2024 and has held it in 9 quarters since. 57 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

Yousif Capital Management held 7,192 shares of Krystal Biotech worth $2.67M as of Q2 2026.
Yousif Capital Management bought 61 Krystal Biotech shares in Q2 2026, an estimated $18.2K.
Krystal Biotech made up 0.03% of Yousif Capital Management's portfolio in Q2 2026, its #550 holding.
Yousif Capital Management first reported a position in Krystal Biotech in Q2 2024 and has held it in 9 quarters since.
57 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.